ProfileGDS4718 / 221583_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 34% 54% 96% 47% 39% 30% 28% 30% 32% 29% 31% 32% 28% 27% 28% 49% 32% 28% 49% 40% 38% 38% 36% 35% 45% 27% 36% 31% 33% 28% 40% 64% 32% 32% 47% 28% 24% 46% 38% 96% 31% 27% 57% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7277834
GSM549102patient 115, normal, homogenized [OPG study]5.7894554
GSM549104patient 119, normal, homogenized [OPG study]10.464996
GSM549108patient 138, normal, homogenized [OPG study]5.3915347
GSM549119patient 077, normal, homogenized [OPG study]4.9671539
GSM549133patient 032, cancer, homogenized [OPG study]4.5033330
GSM549139patient 042, cancer, homogenized [OPG study]4.4258828
GSM549099patient 107, normal, homogenized [OPG study]4.5476630
GSM549109patient 139, normal, homogenized [OPG study]4.6386732
GSM549110patient 046, normal, homogenized [OPG study]4.5193929
GSM549114patient 063, normal, homogenized [OPG study]4.5580431
GSM549122patient 082, normal, homogenized [OPG study]4.6243132
GSM549134patient 033, cancer, homogenized [OPG study]4.4528
GSM549136patient 036, cancer, homogenized [OPG study]4.3501127
GSM549140patient 044, cancer, homogenized [OPG study]4.4203228
GSM549111patient 047, normal, homogenized [OPG study]5.4653549
GSM549113patient 057, normal, homogenized [OPG study]4.5524532
GSM549132patient 031, cancer, homogenized [OPG study]4.4630328
GSM549137patient 038, cancer, homogenized [OPG study]5.4714549
GSM549142patient 047, cancer, homogenized [OPG study]5.1265140
GSM549100patient 110, normal, homogenized [OPG study]4.9007338
GSM549107patient 135, normal, homogenized [OPG study]4.8540538
GSM549115patient 068, normal, homogenized [OPG study]4.7630536
GSM549116patient 072, normal, homogenized [OPG study]4.7122335
GSM549120patient 078, normal, homogenized [OPG study]5.2291145
GSM549131patient 030, cancer, homogenized [OPG study]4.3760327
GSM549118patient 074, normal, homogenized [OPG study]4.7915936
GSM549129patient 027, cancer, homogenized [OPG study]4.6034131
GSM549123patient 088, normal, homogenized [OPG study]4.6607133
GSM549124patient 006, cancer, homogenized [OPG study]4.4814428
GSM549126patient 015, cancer, homogenized [OPG study]4.9812240
GSM549128patient 025, cancer, homogenized [OPG study]6.4482264
GSM549103patient 117, normal, homogenized [OPG study]4.6757932
GSM549117patient 073, normal, homogenized [OPG study]4.5893832
GSM549138patient 041, cancer, homogenized [OPG study]5.3084247
GSM549141patient 045, cancer, homogenized [OPG study]4.3884328
GSM549130patient 028, cancer, homogenized [OPG study]4.3020824
GSM549101patient 111, normal, homogenized [OPG study]5.3395146
GSM549105patient 128, normal, homogenized [OPG study]4.9331438
GSM549106patient 134, normal, homogenized [OPG study]10.760396
GSM549112patient 048, normal, homogenized [OPG study]4.584731
GSM549125patient 011, cancer, homogenized [OPG study]4.4108427
GSM549127patient 024, cancer, homogenized [OPG study]5.947857
GSM549135patient 035, cancer, homogenized [OPG study]4.3912128